The Non-Invasive Prenatal Test (NIPT) is a DNA test on maternal blood to safely and reliably screen pregnancies for the most common fetal aneuploidies Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome) and Trisomy 13 (Edwards syndrome).The fetal sex can also be determined.
Although NIPT can be performed without specific indication, it might be most appropriate in pregnancies with an increased risk for fetal aneuploidy based upon a high maternal age (> 40 yrs) or abnormal result of the first trimester screening. In these cases NIPT is an alternative for invasive tests, where there is a risk of a miscarriage. The reliability of NIPT results is very high (more than 99% for Down syndrome), which is much higher than the reliability of first trimester screening (80 %)
The maternal blood can be taken from week 10 of the pregnancy. The sample has to be sent by Express mail to GENDIA‘s lab in Antwerp, Belgium, and arrive there within 2 days of withdrawal.
NIPT takes 1-2 weeks to complete from arrival of the sample in the GENDIA lab.
For more information: see our website www.DOWNsyndromeNIPT.info
If you want NIPT, please email us at NIPT@GENDIA.net